Skip to content

STRAUMANN BONE LEVEL TAPERED IMPLANT SLA Titanium BL (REF 021.7414)Recalls & reported problems

Institut Straumann AG · Bone Level Tapered Implant, D 4.8mm RC, SLA® 14mm, Ti, Loxim™ · Class 2 · Implant

All models of STRAUMANN BONE LEVEL TAPERED IMPLANT (39)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann Bone Level dental implant is a root-form implant placed in the jawbone. The 446 reports mostly describe implants that did not bond with the bone, and the patient problems listed include tissue scarring, pain and infection. There are 446 injuries and no deaths, and no recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
454
Deaths reported
0
Injuries reported
454
Recalls naming it
0

Summary

The FDA's MAUDE database contains 454 adverse event reports that list this exact device (DI 07630031707512), received between Sep 12, 2019 and Sep 28, 2026 — classified as 454 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (368 reports).

2 other recalls cover devices cleared under the same FDA submission (K140878); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 6 reportsDec 2023: 5 reportsJan 2024: 6 reportsFeb 2024: 9 reportsMar 2024: 10 reportsApr 2024: 5 reportsMay 2024: 6 reportsJun 2024: 5 reportsJul 2024: 7 reportsAug 2024: 4 reportsSep 2024: 22 reportsOct 2024: 6 reportsNov 2024: 11 reportsDec 2024: 11 reportsJan 2025: 11 reportsFeb 2025: 9 reportsMar 2025: 7 reportsApr 2025: 2 reportsMay 2025: 0 reportsJun 2025: 20 reportsJul 2025: 6 reportsAug 2025: 12 reportsSep 2025: 7 reportsOct 2025: 15 reportsNov 2025: 9 reportsDec 2025: 28 reportsJan 2026: 7 reportsFeb 2026: 4 reportsMar 2026: 10 reportsApr 2026: 5 reportsMay 2026: 15 reportsJun 2026: 4 reportsJul 2026: 10 reportsAug 2026: 14 reportsSep 2026: 8 reportsOct 2026: 0 reports20242025202628
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate368
  • Loss of Osseointegration55
  • Adverse Event Without Identified Device or Use Problem29
  • Difficult to Insert2
  • Fracture2
  • Therapeutic or Diagnostic Output Failure1

Patient problems

  • No Clinical Signs, Symptoms or Conditions260
  • Fibrosis132
  • Pain97
  • Unspecified Infection31
  • Hemorrhage/Blood Loss/Bleeding19
  • Swelling/ Edema16
  • Tissue Damage12
  • Inflammation9

Recent adverse event reports

The 25 most recent of 454 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920908 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920200 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920198 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in ADA 30. On (B)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. No product was returned to the manufacturer. At the event the patient experienced: Pain. No further patient complications were reported.

    Patient problems: Pain

    MAUDE report 50718951 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 19. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. No product was returned to the manufacturer. At the event the patient experienced: Pain and Bleeding. No further patient complications were reported.

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Pain

    MAUDE report 50718949 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in ADA 19. On (B)(6) 2026 non-osseointegration was verified. Patient presented with bone type III. No product was returned to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50718944 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Pain

    MAUDE report 50718939 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in ADA 30. On (B)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. At the event the patient experienced: Pain. No further patient complications were reported.

    Patient problems: Pain

    MAUDE report 50718928 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 46. Details of surgery: Implant surface not completely covered with bone. On (b)(6) 2026, non-osseointegration was verified. Patient presented with fair oral hygiene. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50284267 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in FDI 27. Details of surgery: Primary stability not achieved and Implant surface not completely covered with bone. On (b)(6) 2026, non-osseointegration was verified. Patient presented with fair oral hygiene. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50282620 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in FDI 27. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50282044 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted 2025 (b)(6) in FDI 15. On 2026 (b)(6), non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50282031 ↗
  • InjuryAug 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 11. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50198979 ↗
  • InjuryAug 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 34. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50198950 ↗
  • InjuryAug 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in FDI 34. On (B)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50198933 ↗
  • InjuryAug 4, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 45. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. No product was returned to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50132022 ↗
  • InjuryAug 4, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 43. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. No product was returned to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50132020 ↗
  • InjuryAug 3, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50120106 ↗
  • InjuryAug 3, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50120101 ↗
  • InjuryAug 3, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in FDI 25. On (B)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50120042 ↗
  • InjuryAug 3, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (B)(6) 2024 in ADA 19. Details of surgery: Implant surface not completely covered with bone. On (B)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Peri-implantitis, Pain, Mobility and Increased Sensitivity. No further patient complications were reported.

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Pain; Unspecified Infection

    MAUDE report 50119808 ↗
  • InjuryAug 3, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (B)(6) 2024 in ADA 19. Details of surgery: Implant surface not completely covered with bone. On (B)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Peri-implantitis, Pain, Mobility and Increased Sensitivity. No further patient complications were reported.

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Pain; Unspecified Infection

    MAUDE report 50118168 ↗
  • InjuryJul 28, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 23. Details of surgery: Implant surface not completely covered with bone. On (b)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. At the event the patient experienced: Pain and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Pain

    MAUDE report 50058881 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2025 in FDI 42. On (B)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50023427 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted on (b)(6)2026 in FDI 36. On (b)(6)2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50023219 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K140878. One submission often covers many models, so check the product and lot details in each record.

  • Z-2935-2026 · Jul 16, 2026 · Open, Classified
    Straumann Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim (Article 021.5314); implant, endosseous, root-form
  • Z-0117-2015 · Sep 19, 2014 · Terminated
    Straumann Bone Level Tapered Implant 04.1 mm RC, SLActive 8mm, Roxolid, Loxim Article Number: 021 .5308 Dental implants are intended for surgical placement in maxillary and/or man

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page